Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocellular carcinoma

Genes Chromosomes and Cancer

Volumn 31, Issue 3, 2001, Pages 221-227

  Wang, Gang ^a,b   Zhao, Yan ^b   Liu, Xiaoming ^b   Wang, Lu ^c   Wu, Chungen ^b   Zhang, Weiling ^b   Liu, Wanqing ^b   Zhang, Pingping ^a   Cong, Wenming ^d   Zhu, Yuanrong ^e   Zhang, Lisheng ^f   Chen, Saijuan ^c   Wan, Dafang ^a   Zhao, Xintai ^a   Huang, Wei ^b   Gu, Jianren ^a  

^a SHANGHAI CANCER INSTITUTE   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^d EASTERN HEPATOBILIARY SURGERY HOSPITAL   (China)

^e QIDONG LIVER CANCER INSTITUTE   (China)

^f Guangxi Cancer Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ARTICLE; AUTOSOME; CANCER GRADING; CANCER SIZE; CARCINOGENESIS; CHINESE; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; SOMATIC MUTATION;

ADULT; AGED; ALLELIC IMBALANCE; CARCINOMA, HEPATOCELLULAR; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENE AMPLIFICATION; HUMANS; LIVER NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; NUCLEIC ACID HYBRIDIZATION;

EID: 0034998462     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.1138     Document Type: Article

References (28)

1. Hepatocellular carcinoma
2. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma
3. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours
4. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations
5. Expression of p53 and 17p allelic loss in colorectal carcinoma
6. Hepatitis C and hepatocellular carcinoma
7. Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma
8. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China
9. Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours
10. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors
11. Etiology, screening, and treatment of hepatocellular carcinoma
12. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers
13. Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene
14. Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis
15. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization
16. Hepatocellular carcinoma: From gene to public health
17. Comprehensive allelotyping of human hepatocellular carcinoma
18. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis
19. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma
20. Allelotype analysis of hepatocellular carcinoma
21. Frequent microsatellite instability in post hepatitis B viral cirrhosis
22. Microsatellite instability in European hepatocellular carcinoma
23. Hepatocellular carcinoma
24. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan
25. Hepatocellular carcinoma. A worldwide problem and the major risk factors
26. High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor
27. Allelotype of gastric adenocarcinoma